Centerpoint Advisors’s Amgen AMGN Stock Holding History

Centerpoint Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$12K	Hold	28	–	–	﹤0.01%	257
2026 Q2	$10K	Hold	28	–	–	﹤0.01%	331
2026 Q1	$10K	Hold	28	–	–	﹤0.01%	315
2025 Q4	$9K	Sell	28 -8	-22%	-$2.54K	﹤0.01%	323
2025 Q3	$10K	Sell	36 -77	-68%	-$22.3K	﹤0.01%	329
2025 Q2	$32K	Sell	113 -71	-39%	-$20.1K	0.01%	184
2025 Q1	$57K	Hold	184	–	–	0.02%	152
2024 Q4	$48K	Hold	184	–	–	0.02%	181
2024 Q3	$59K	Hold	184	–	–	0.02%	160
2024 Q2	$57K	Buy	+184	New	+$54.1K	0.02%	156
2021 Q3	–	Sell	-34	Closed	-$8K	–	292
2021 Q2	$8K	Buy	+34	New	+$8.36K	﹤0.01%	211
2021 Q1	–	Sell	-33	Closed	-$8K	–	267
2020 Q4	$8K	Hold	33	–	–	0.01%	176
2020 Q3	$8K	Hold	33	–	–	0.01%	152
2020 Q2	$8K	Hold	33	–	–	0.01%	165
2020 Q1	$7K	Hold	33	–	–	0.01%	158
2019 Q4	$8K	Hold	33	–	–	0.01%	175
2019 Q3	$6K	Hold	33	–	–	﹤0.01%	184
2019 Q2	$6K	Buy	+33	New	+$5.91K	﹤0.01%	178
2018 Q2	–	Sell	-41	Closed	-$7K	–	366
2018 Q1	$7K	Buy	+41	New	+$7.53K	0.01%	170

Other funds holding AMGN

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Centerpoint Advisors's AMGN Position: Q3 2026 in Review

Centerpoint Advisors held its Amgen (AMGN) position steady in Q3 2026 at 28 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #257.

Centerpoint Advisors first reported a position in AMGN in Q1 2018 and has held it in 19 quarters since. The position peaked at $59K in Q3 2024. 2,318 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

Centerpoint Advisors held 28 shares of Amgen worth $12K as of Q3 2026.
Centerpoint Advisors left its Amgen share count unchanged in Q3 2026.
Amgen made up ﹤0.01% of Centerpoint Advisors's portfolio in Q3 2026, its #257 holding.
Centerpoint Advisors first reported a position in Amgen in Q1 2018 and has held it in 19 quarters since.
Centerpoint Advisors's Amgen position peaked at $59K in Q3 2024.
2,318 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Centerpoint Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.